Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer

REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer

Condition:   Prostate Cancer Metastatic
Interventions:   Drug: REGN2810;   Drug: Degarelix;   Drug: Leuprolide Acetate;   Drug: Docetaxel
Sponsors:   Mark Stein;   Regeneron Pharmaceuticals
Recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 21, 2019 / by / in
Comments